"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 3 | 4 |
| 1996 | 4 | 3 | 7 |
| 1997 | 1 | 1 | 2 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 4 | 5 |
| 2000 | 4 | 4 | 8 |
| 2001 | 8 | 4 | 12 |
| 2002 | 7 | 7 | 14 |
| 2003 | 15 | 3 | 18 |
| 2004 | 19 | 6 | 25 |
| 2005 | 15 | 5 | 20 |
| 2006 | 18 | 7 | 25 |
| 2007 | 29 | 8 | 37 |
| 2008 | 35 | 12 | 47 |
| 2009 | 26 | 6 | 32 |
| 2010 | 35 | 12 | 47 |
| 2011 | 27 | 7 | 34 |
| 2012 | 30 | 11 | 41 |
| 2013 | 45 | 6 | 51 |
| 2014 | 40 | 9 | 49 |
| 2015 | 31 | 4 | 35 |
| 2016 | 39 | 9 | 48 |
| 2017 | 52 | 8 | 60 |
| 2018 | 38 | 11 | 49 |
| 2019 | 50 | 7 | 57 |
| 2020 | 58 | 7 | 65 |
| 2021 | 50 | 5 | 55 |
| 2022 | 57 | 0 | 57 |
| 2023 | 55 | 2 | 57 |
| 2024 | 38 | 16 | 54 |
| 2025 | 15 | 5 | 20 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Eche-Ugwu IJ, Dunnack Yackel H, Pozzar RA, Hammer MJ, Cooley ME. A Qualitative Descriptive Study to Assess Experiences and Care Needs of Patients With Cancer During the COVID-19 Pandemic. Oncol Nurs Forum. 2025 Apr 23; 52(3):205-216.
-
Huang Z, Li Y, Bucci V, Haran JP. Decoding cancer prognosis with deep learning: the ASD-cancer framework for tumor microenvironment analysis. mSystems. 2025 May 20; 10(5):e0145524.
-
Eche-Ugwu IJ, Mazzola E, Stevens SE, Wolfe J, Feraco AM. Illness Uncertainty in Parents of Children With Cancer-An Exploratory Analysis to Inform Intervention Development. Pediatr Blood Cancer. 2025 Jul; 72(7):e31726.
-
Gutmann DH, Boehm JS, Karlsson EK, Padron E, Seshadri M, Wallis D, Snyder JC. Precision preclinical modeling to advance cancer treatment. J Natl Cancer Inst. 2025 Apr 01; 117(4):586-594.
-
Gerber WK, Xie Y, Patel SA. Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors. JCO Precis Oncol. 2025 Mar; 9:e2400753.
-
Youk H, Lee HY, Lee EY, Kim YJ, Park JY, Choi HG, Kim HS, Lee JW. Association between osteoporosis under treatment and all-cause and specific-cause mortalities: a nationwide retrospective cohort study in South Korea. BMC Musculoskelet Disord. 2025 Mar 24; 26(1):291.
-
Carr AS, Vonberg FW, Koay S, Young K, Shaw H, Olsson-Brown A, Willis M. Neurological complications of immune checkpoint inhibitors: a practical guide. Pract Neurol. 2025 Mar 14; 25(2):116-126.
-
Fantasia HC. Addressing Alcohol Use and Cancer Risk. Nurs Womens Health. 2025 Apr; 29(2):75-77.
-
Dabbagh Z, Najjar R, Kamberi A, Gerber BS, Singh A, Soni A, Cutrona SL, McManus DD, Faro JM. Usability and Implementation Considerations of Fitbit and App Intervention for Diverse Cancer Survivors: Mixed Methods Study. JMIR Cancer. 2025 Feb 24; 11:e60034.
-
Pozzar RA, Dunnack Yackel H, Eche-Ugwu IJ, Hammer MJ, Cooley ME. Cancer Care Experiences, Resilience, and Psychological Symptoms Among Patients During the COVID-19 Pandemic: A Mixed-Methods Study. Oncol Nurs Forum. 2025 Feb 18; 52(2):97-112.